Moolec Science (NASDAQ:MLEC – Get Free Report) is anticipated to announce its earnings results before the market opens on Tuesday, March 11th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $1.32 million for the quarter.
Moolec Science (NASDAQ:MLEC – Get Free Report) last released its quarterly earnings data on Friday, January 31st. The company reported ($0.05) EPS for the quarter. Moolec Science had a negative return on equity of 119.34% and a negative net margin of 140.32%.
Moolec Science Price Performance
NASDAQ MLEC opened at $0.75 on Tuesday. Moolec Science has a one year low of $0.53 and a one year high of $3.25. The stock has a 50-day moving average of $0.77 and a 200 day moving average of $0.84. The company has a market capitalization of $28.72 million, a price-to-earnings ratio of -3.56 and a beta of -0.47. The company has a debt-to-equity ratio of 3.24, a quick ratio of 0.76 and a current ratio of 1.51.
Moolec Science Company Profile
Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product.
See Also
- Five stocks we like better than Moolec Science
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- What is a penny stock? A comprehensive guide
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- 3 Fintech Stocks With Good 2021 Prospects
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Moolec Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moolec Science and related companies with MarketBeat.com's FREE daily email newsletter.
